These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15035597)

  • 1. Off-label pharmaceutical use: balancing information, risks, and benefits.
    Kozma CM
    Manag Care Interface; 2004 Jan; 17(1):29-30. PubMed ID: 15035597
    [No Abstract]   [Full Text] [Related]  

  • 2. Off-label drugs: question your doctor.
    Consum Rep; 2007 Jun; 72(6):47. PubMed ID: 17632948
    [No Abstract]   [Full Text] [Related]  

  • 3. Be wary of recommending off-label use of meds.
    Luttrull S
    Adv Nurse Pract; 2001 Feb; 9(2):18. PubMed ID: 12416047
    [No Abstract]   [Full Text] [Related]  

  • 4. Uses of drugs not described in the package insert (off-label uses).
    Committee on Drugs. American Academy of Pediatrics
    Pediatrics; 2002 Jul; 110(1 Pt 1):181-3. PubMed ID: 12093968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Going off-label without venturing off-course: evidence and ethical off-label prescribing.
    Largent EA; Miller FG; Pearson SD
    Arch Intern Med; 2009 Oct; 169(19):1745-7. PubMed ID: 19858430
    [No Abstract]   [Full Text] [Related]  

  • 6. Positive outcomes through the appropriate use of off-label prescribing.
    Bright JL
    Arch Intern Med; 2006 Dec 11-25; 166(22):2554-5; author reply 2555. PubMed ID: 17159026
    [No Abstract]   [Full Text] [Related]  

  • 7. Are "off-labels" legal?
    Price EC
    Mich Health Hosp; 1998; 34(6):20-1. PubMed ID: 10187136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications.
    Kumar P; Walker JK; Hurt KM; Bennett KM; Grosshans N; Fotis MA
    J Pediatr; 2008 Mar; 152(3):412-5. PubMed ID: 18280851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing potential risks and evaluating expected benefits.
    Shaya FT; Gu A
    Manag Care Interface; 2005 May; 18(5):27-30. PubMed ID: 15941187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rationale for off-label prescriptions.
    Johns Hopkins Med Lett Health After 50; 2000 May; 12(3):6. PubMed ID: 10798286
    [No Abstract]   [Full Text] [Related]  

  • 11. Unlicensed and off-label drug use in children.
    Bavdekar SB; Gogtay NJ
    J Postgrad Med; 2005; 51(4):249-52. PubMed ID: 16388164
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.
    Novak E; Allen PJ
    Pediatr Nurs; 2007; 33(1):64-70. PubMed ID: 17411005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A physician's prerogative to prescribe drugs for off-label uses during pregnancy.
    Rayburn WF
    Obstet Gynecol; 1993 Jun; 81(6):1052-5. PubMed ID: 8497349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Getting SMARTer?
    Weinberg JM
    Cutis; 2005 Feb; 75(2):83, 91. PubMed ID: 15773526
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk management and intrusions on medical practice: striking a balance.
    Enzi MB; Kennedy EM
    Health Aff (Millwood); 2007; 26(3):678-80. PubMed ID: 17485743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

  • 17. Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription.
    Verhagen CC; Niezink AG; Engels YY; Hekster YY; Doornebal JJ; Vissers KC
    Pain Pract; 2008; 8(3):157-63. PubMed ID: 18373512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unlicensed and off-label drug use in children: implications for safety.
    Choonara I
    Expert Opin Drug Saf; 2004 Mar; 3(2):81-3. PubMed ID: 15006712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label or off-limits?
    Ratner M; Gura T
    Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236
    [No Abstract]   [Full Text] [Related]  

  • 20. A decision analysis model to justify and approve off-label drug use in pain and palliative care.
    Diaz JH
    Pain Pract; 2008; 8(3):153-4. PubMed ID: 18476893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.